Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

MLA

Gaulton, K.(Kyle), et al. Genetic Fine Mapping and Genomic Annotation Defines Causal Mechanisms at Type 2 Diabetes Susceptibility Loci. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn957098489&authtype=sso&custid=ns315887.

APA

Gaulton, K. (Kyle), Ferreira, T. (Teresa), Lee, Y. (Yeji), Raimondo, A. (Anne), Mägi, R. (Reedik), Reschen, M. E. (Michael E. ., Mahajan, A. (Anubha), Locke, A. (Adam), Rayner, N. W. (Nigel W., Robertson, N. R. (Neil), Scott, R. A. (Robert), Prokopenko, I. (Inga), Scott, L. J. (Laura), Green, T. (Todd), Sparsø, T. (Thomas), Thuillier, D. (Dorothee), Yengo, L. (Loic), Grallert, H. (Harald), Wahl, S. (Simone), … Morris, A. P. (Andrew). (2015). Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.

Chicago

Gaulton, K. (Kyle), T. (Teresa) Ferreira, Y. (Yeji) Lee, A. (Anne) Raimondo, R. (Reedik) Mägi, M.E. (Michael E.) Reschen, A. (Anubha) Mahajan, et al. 2015. “Genetic Fine Mapping and Genomic Annotation Defines Causal Mechanisms at Type 2 Diabetes Susceptibility Loci.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn957098489&authtype=sso&custid=ns315887.